» Articles » PMID: 271951

Activation of Factor IX by the Reaction Product of Tissue Factor and Factor VII: Additional Pathway for Initiating Blood Coagulation

Overview
Specialty Science
Date 1977 Dec 1
PMID 271951
Citations 125
Authors
Affiliations
Soon will be listed here.
Abstract

A study was carried out on mechanisms, independent of activated Factor XI, capable of activating Factor IX. The reaction product of tissue factor and Factor VII functioned as a potent Factor IX activator in the assay system used. Activated Factor IX itself activated Factor X; thrombin failed to activate Factor IX. Sodium dodecyl sulfate/polyacrylamide gel electrophoresis confirmed that the reaction product of tissue factor and Factor VII activated Factor IX, with replacement of the band corresponding to native factor IX [molecular weight (Mr) 55,000] by bands corresponding to the heavy chain (Mr 27,000) and light chain (Mr 17,000) of activated Factor IX. When either Factor VII or calcium ions were left out of incubation mixtures, the band of native Factor IX persisted unchanged. Contact of blood with tissue factor represents a second mechanism, bypassing activated Factor XI, for the activation of Factor IX during hemostasis. It may help to explain the discrepancy between the mild bleeding of hereditary Factor XI deficiency and the severe bleeding of hereditary Factor IX deficiency.

Citing Articles

Back to basics: the coagulation pathway.

Park S, Park J Blood Res. 2024; 59(1):35.

PMID: 39466528 PMC: 11519239. DOI: 10.1007/s44313-024-00040-8.


Blood coagulation factor IX: structural insights impacting hemophilia B therapy.

Bos M, van Diest R, Monroe D Blood. 2024; 144(21):2198-2210.

PMID: 38996207 PMC: 11600082. DOI: 10.1182/blood.2023023276.


Plasma kallikrein supports FXII-independent thrombin generation in mouse whole blood.

Wan J, Dhrolia S, Kasthuri R, Prokopenko Y, Ilich A, Saha P Blood Adv. 2024; 8(12):3045-3057.

PMID: 38593231 PMC: 11215197. DOI: 10.1182/bloodadvances.2024012613.


Impact of tissue factor expression and administration routes on thrombosis development induced by mesenchymal stem/stromal cell infusions: re-evaluating the dogma.

Hoang V, Le D, Hoang D, Phan T, Ngo L, Nguyen T Stem Cell Res Ther. 2024; 15(1):56.

PMID: 38414067 PMC: 10900728. DOI: 10.1186/s13287-023-03582-3.


Proteomics reveals specific biological changes induced by the normothermic machine perfusion of donor kidneys with a significant up-regulation of Latexin.

Zaza G, Neri F, Bruschi M, Granata S, Petretto A, Bartolucci M Sci Rep. 2023; 13(1):5920.

PMID: 37041202 PMC: 10090051. DOI: 10.1038/s41598-023-33194-z.


References
1.
RAPAPORT S, SCHIFFMAN S, PATCH M, AMES S . The importance of activation of antihemophilic globulin and proaccelerin by traces of thrombin in the generation of intrinsic prothrombinase activity. Blood. 1963; 21:221-36. View

2.
BELL W, ALTON H . A brain extract as a substitute for platelet suspensions in the thromboplastin generation test. Nature. 1954; 174(4436):880-1. DOI: 10.1038/174880a0. View

3.
LOWRY O, ROSEBROUGH N, FARR A, RANDALL R . Protein measurement with the Folin phenol reagent. J Biol Chem. 1951; 193(1):265-75. View

4.
Kasper C, Osterud B, Minami J, Shonick W, RAPAPORT S . Hemophilia B: characterization of genetic variants and detection of carriers. Blood. 1977; 50(3):351-66. View

5.
Osterud B, RAPAPORT S, Lavine K . Factor V activity of platelets: evidence for an activated factor V molecule and for a platelet activator. Blood. 1977; 49(5):819-34. View